0001209191-18-062117.txt : 20181211 0001209191-18-062117.hdr.sgml : 20181211 20181211194114 ACCESSION NUMBER: 0001209191-18-062117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181207 FILED AS OF DATE: 20181211 DATE AS OF CHANGE: 20181211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hindman James M. CENTRAL INDEX KEY: 0001617615 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35890 FILM NUMBER: 181229854 MAIL ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Millendo Therapeutics, Inc. CENTRAL INDEX KEY: 0001544227 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 451472564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 NORTH MAIN STREET, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 BUSINESS PHONE: 734-845-9000 MAIL ADDRESS: STREET 1: 301 NORTH MAIN STREET, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 FORMER COMPANY: FORMER CONFORMED NAME: OvaScience, Inc. DATE OF NAME CHANGE: 20120308 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-07 0 0001544227 Millendo Therapeutics, Inc. MLND 0001617615 Hindman James M. C/O MILLENDO THERAPEUTICS, INC. 301 N. MAIN ST., SUITE 100 ANN ARBOR MI 48104 1 0 0 0 Stock Option (right to buy) 6.59 2018-12-07 4 A 0 17509 A 2026-08-09 Common Stock 17509 17509 D Stock Option (right to buy) 16.40 2018-12-07 4 A 0 3720 A 2028-08-23 Common Stock 3720 3720 D Twenty-five percent (25%) of the shares subject to the option vested on June 17, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Received in connection with the merger of Millendo Therapeutics, Inc. ("Millendo") into the Issuer (the "Merger") in exchange for a stock option to acquire 235,341 shares of Millendo common stock for $0.49 per share. Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Received in connection with the Merger in exchange for a stock option to acquire 50,000 shares of Millendo common stock for $1.22 per share. /s/ Jeffery M. Brinza, Attorney-in-Fact 2018-12-11